当期変動額合計、減損損失、連結範囲の変動他1件
- 【期間】
| 年度 | 当期変動額合計 | 減損損失 | 連結範囲の変動 | 売上高 - 医薬品 |
|---|
| 2009/12 | - | | 0.91億 | | - | | - | |
| 2010/03 | - | | 1.19億 | +30.8% | - | | - | |
| 2011/03 | - | | 19.9億 | 大幅増 | - | | - | |
| 2012/03 | - | | 15.1億 | -24.2% | - | | - | |
| 2013/03 | 221億 | | 0.76億 | -95% | - | | - | |
| 2013/09 | - | | 6.68億 | +778.9% | - | | 596億 | |
| 2014/03 | 75.1億 | -66% | 36.1億 | +440.7% | 353百万 | | - | |
| 2014/09 | - | | 4.28億 | -88.2% | - | | 568億 | -4.8% |
| 2015/03 | 530億 | +605.2% | 36.2億 | +746.5% | - | | - | |
| 2015/09 | - | | 13.9億 | -61.7% | - | | 761億 | +34.1% |
| 2016/03 | 389億 | -26.7% | 18.6億 | +34.1% | - | | - | |
| 2016/09 | - | | 0.51億 | -97.3% | - | | 721億 | -5.3% |
| 2017/03 | 380億 | -2.1% | 7.54億 | 大幅増 | 26百万 | -92.6% | - | |
| 2017/09 | - | | 1.14億 | -84.9% | - | | 778億 | +7.8% |
| 2018/03 | 380億 | -0.1% | 42.1億 | 大幅増 | - | | - | |
| 2018/09 | - | | 10.1億 | -76.1% | - | | 876億 | +12.6% |
| 2019/03 | 655億 | +72.3% | 122億 | 大幅増 | -261百万 | 赤転 | - | |
| 2019/09 | - | | 7.56億 | -93.8% | - | | 954億 | +8.9% |
| 2019/12 | - | | 19.9億 | +163.4% | - | | - | |
| 2020/03 | 374億 | -42.8% | 23.9億 | +20% | - | | - | |
| 2020/09 | - | | 10.6億 | -55.9% | - | | 891億 | -6.6% |
| 2020/12 | - | | 22.3億 | +111.5% | - | | - | |
| 2021/03 | 618億 | +65% | 27.6億 | +23.8% | -130百万 | 赤縮 | - | |
| 2021/09 | - | | 5.17億 | -81.3% | - | | 921億 | +3.3% |
| 2021/12 | - | | 6.38億 | +23.4% | - | | - | |
| 2022/03 | 540億 | -12.6% | 20.1億 | +214.3% | 262百万 | 黒転 | - | |
| 2022/09 | - | | 2.39億 | -88.1% | - | | 972億 | +5.5% |
| 2022/12 | - | | 2.39億 | ±0% | - | | - | |
| 2023/03 | 383億 | -29.1% | 2.57億 | +7.5% | - | | - | |
| 2023/09 | - | | 1.29億 | -49.8% | - | | 1009億 | +3.8% |
| 2023/12 | - | | 6.2億 | +380.6% | - | | - | |
| 2024/03 | 365億 | -4.7% | 155億 | 大幅増 | -59百万 | 赤転 | - | |
| 2024/09 | - | | 1.71億 | -98.9% | - | | 1139億 | +12.9% |
